Hims & Hers Health Basic EPS 2020-2025 | HIMS
Hims & Hers Health annual/quarterly basic eps history and growth rate from 2020 to 2025. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
- Hims & Hers Health basic eps for the quarter ending June 30, 2025 was $0.19, a 216.67% increase year-over-year.
- Hims & Hers Health basic eps for the twelve months ending June 30, 2025 was $0.88, a 1000% increase year-over-year.
- Hims & Hers Health annual basic eps for 2024 was $0.001B, a 627.27% decline from 2023.
- Hims & Hers Health annual basic eps for 2023 was $-0B, a 65.63% decline from 2022.
- Hims & Hers Health annual basic eps for 2022 was $-0B, a 44.83% decline from 2021.
| Hims & Hers Health Annual Basic EPS | |
|---|---|
| 2024 | $0.58 |
| 2023 | $-0.11 |
| 2022 | $-0.32 |
| 2021 | $-0.58 |
| 2020 | $-0.51 |
| 2019 | $-2.07 |
| 2018 | $0.00 |
| Hims & Hers Health Quarterly Basic EPS | |
|---|---|
| 2025-06-30 | $0.19 |
| 2025-03-31 | $0.22 |
| 2024-12-31 | $0.12 |
| 2024-09-30 | $0.35 |
| 2024-06-30 | $0.06 |
| 2024-03-31 | $0.05 |
| 2023-12-31 | $0.01 |
| 2023-09-30 | $-0.04 |
| 2023-06-30 | $-0.03 |
| 2023-03-31 | $-0.05 |
| 2022-12-31 | $-0.05 |
| 2022-09-30 | $-0.09 |
| 2022-06-30 | $-0.10 |
| 2022-03-31 | $-0.08 |
| 2021-12-31 | $-0.11 |
| 2021-09-30 | $-0.08 |
| 2021-06-30 | $-0.05 |
| 2021-03-31 | $-0.34 |
| 2020-12-31 | $-0.15 |
| 2020-09-30 | $-0.16 |
| 2020-06-30 | $-0.03 |
| 2020-03-31 | $-0.17 |
| 2019-12-31 | |
| 2019-09-30 | $-0.09 |
| 2019-06-30 | $-0.07 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $9.572B | $1.477B |
| Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $43.991B | 53.84 |
| Tempus AI (TEM) | United States | $13.179B | 0.00 |
| Doximity (DOCS) | United States | $12.725B | 56.62 |
| IRhythm Technologies (IRTC) | United States | $5.461B | 0.00 |
| Hinge Health (HNGE) | United States | $4.399B | 0.00 |
| Privia Health (PRVA) | United States | $2.828B | 209.46 |
| Inspire Medical Systems (INSP) | United States | $2.771B | 40.74 |
| Heartflow (HTFL) | $2.557B | 0.00 | |
| Phreesia (PHR) | United States | $1.884B | 0.00 |
| Enovis (ENOV) | United States | $1.766B | 9.34 |
| 10x Genomics (TXG) | United States | $1.744B | 0.00 |
| Omnicell (OMCL) | United States | $1.497B | 28.84 |
| Schrodinger (SDGR) | United States | $1.436B | 0.00 |
| Azenta (AZTA) | United States | $1.400B | 61.08 |
| Clover Health Investments (CLOV) | United States | $1.343B | 0.00 |
| Claritev (CTEV) | United States | $1.135B | 0.00 |
| Evolent Health (EVH) | United States | $1.134B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.679B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.652B | 0.00 |
| Veradigm (MDRX) | United States | $0.531B | 0.00 |
| Standard BioTools (LAB) | United States | $0.481B | 0.00 |
| Talkspace (TALK) | United States | $0.445B | 133.00 |
| Butterfly Network (BFLY) | United States | $0.405B | 0.00 |
| Carlsmed (CARL) | United States | $0.354B | 0.00 |
| TruBridge (TBRG) | United States | $0.300B | 52.53 |
| Outset Medical (OM) | United States | $0.247B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.239B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.234B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.213B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.195B | 0.00 |
| CapsoVision (CV) | United States | $0.175B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.168B | 0.00 |
| CareCloud (CCLD) | United States | $0.163B | 7.38 |
| American Well (AMWL) | United States | $0.111B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.109B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.077B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.072B | 0.00 |
| Pulmonx (LUNG) | United States | $0.070B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.060B | 0.00 |
| 111 (YI) | China | $0.056B | 0.00 |
| HeartBeam (BEAT) | United States | $0.046B | 0.00 |
| Zhongchao (ZCMD) | China | $0.025B | 0.00 |
| Precipio (PRPO) | United States | $0.025B | 0.00 |
| PROFUSA (PFSA) | United States | $0.017B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.013B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |